Membranous Nephropathy Trial Of Rituximab

Team Members
  • Dr. Fernando C. Fervenza - Mayo Clinic & Dr. Daniel Cattran, University Health Network

MENTOR is a multi-center randomized controlled Phase III trial that tests whether B cell targeting with Rituximab is more effective, reduces the number of relapses, and leads to an improved quality of life when compared with treatment with Cyclosporine in patients with IMN.